Nanomedicine manufacturing

The transition from laboratory-scale synthesis to pilot-scale production is a pivotal phase in the drug development process that demands precision, scalability and quality. Scaling up from bench-scale laboratory experiments to compliant bulk drug product manufacturing requires a keen understanding of the process at both scales. At Ardena, we integrate our process and development teams to seamlessly transform innovative drug formulations into commercially viable solutions.

Ardena’s state-of-the-art manufacturing facilities are equipped to handle a high variety of nanoparticle-based products. Each project is unique, and our nanoparticle manufacturing capabilities reflect this. We are adept at manufacturing a variety of bulk drug products and our flexible manufacturing solutions are tailored to meet the specific requirements of your project. Our facilities adhere to the standards of cGMP, ensuring the reliability, consistency and safety of the bulk drug products we manufacture.